Delta Becoming Globally Dominant: WHO

Geneva: The Delta variant, first identified in India, is becoming the globally dominant variant of the disease, the WHO’s chief scientist Soumya Swaminathan said on Friday.

According to the Covid-19 Weekly Epidemiological Update issued by the WHO on June 15, the Delta variant is now being reported in about 80 countries around the world. Another 12 countries and areas are “reporting the detection of B.1.617 without further specification of lineage at this time.”

“The whole situation is so dynamic because of the variants that are now circulating and…the Delta variant is well on its way to becoming the dominant variant globally because of its significantly increased transmissibility,” Swaminathan said responding to a question at a press briefing.

Her remarks came hours after Public Health England said that the number of Delta variant cases has jumped by 33,630 in a week to hit a total of 75,953 in the UK, with the highly transmissible variant now making up 99% of all cases in the country. The rise was a 79% increase on the previous week’s tally. On Friday, vaccinations were opened up to all people over 18 in England.

In Washington, CDC director Rochelle Walensky said she expects the Delta variant will become the dominant coronavirus strain in the US. “As worrisome as this delta strain is with regard to its hyper transmissibility, our vaccines work,” Walensky told ABC News.

The Kremlin in Russia blamed a surge in cases on reluctance to have vaccinations and “nihilism” after a record 9,056 new infections in Moscow, mostly with the Delta variant, fanned fears of a third wave. “According to the latest data, 89.3% of Muscovites (recently) diagnosed with Covid-19 have the mutated, so-called Delta or Indian variant,” the news agency TASS quoted Moscow Mayor Sergei Sobyanin as saying.

In Germany, top public health official predicted Delta would rapidly become the dominant variant there despite rising vaccination rates. Agencies

  • Related Posts

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    New Delhi: Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP in…

    STF busts fake meds racket spread across 6 states

    Dehradun: Uttarakhand special task force (STF) on Friday busted an online fake medicine racket operating through a Facebook page that allegedly sold counterfeit drugs, including cancer medicines, at discounts of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states

    All the Way from Teeth to Tee: Hole in One

    All the Way from Teeth to Tee: Hole in One

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Chemists strike on May 20: Reasons behind today’s all-India strike

    Chemists strike on May 20: Reasons behind today’s all-India strike

    AbbVie loses patent plea for Hep C drug

    AbbVie loses patent plea for Hep C drug